HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hüseyin Ince Selected Research

ACT protocol

8/2021Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hüseyin Ince Research Topics

Disease

18Myocardial Infarction
02/2024 - 08/2005
17Aortic Dissection
10/2015 - 09/2003
16Thrombosis (Thrombus)
01/2022 - 12/2009
11Stroke (Strokes)
08/2022 - 12/2007
10Atrial Fibrillation
03/2024 - 01/2019
9Aortic Valve Stenosis (Aortic Stenosis)
10/2022 - 09/2012
8Heart Failure
01/2023 - 12/2004
8Hemorrhage
08/2022 - 04/2013
7Inflammation (Inflammations)
01/2022 - 08/2006
7Infarction (Infarctions)
01/2021 - 08/2005
5Acute Coronary Syndrome
08/2021 - 09/2004
5Rupture
07/2020 - 09/2003
5Cardiomyopathies (Cardiomyopathy)
07/2019 - 05/2005
5ST Elevation Myocardial Infarction
01/2016 - 08/2005
5Aneurysm (Aneurysms)
03/2015 - 12/2003
4Heart Diseases (Heart Disease)
05/2022 - 05/2005
4Shock
10/2019 - 08/2013
3Cardiac Arrhythmias (Arrythmia)
03/2024 - 05/2018
3Coronary Artery Disease (Coronary Atherosclerosis)
10/2022 - 10/2019
3Infections
01/2022 - 10/2020
3Ventricular Remodeling
01/2020 - 08/2005
3Tachycardia (Tachyarrhythmias)
10/2019 - 05/2005
3Mitral Valve Insufficiency (Mitral Regurgitation)
02/2019 - 07/2014
3Left Ventricular Dysfunction
01/2019 - 12/2004
3Cardiovascular Diseases (Cardiovascular Disease)
06/2015 - 09/2011
3Wounds and Injuries (Trauma)
01/2015 - 10/2006
3Body Weight (Weight, Body)
02/2010 - 08/2005
3Vascular System Injuries
10/2007 - 08/2006
2Ventricular Tachycardia
01/2023 - 05/2005
2Cardiogenic Shock
01/2023 - 10/2014
2Embolism (Embolus)
08/2022 - 12/2020
2Ischemia
01/2021 - 08/2013
2Acute Kidney Injury (Acute Renal Failure)
01/2021 - 10/2020
2Pathologic Constriction (Stenosis)
01/2018 - 07/2014
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2017 - 09/2011
2Mesenteric Ischemia
05/2015 - 08/2013
2Aortic Coarctation
01/2015 - 06/2010
2Pain (Aches)
08/2013 - 11/2005
2Renal Insufficiency (Renal Failure)
08/2013 - 09/2008
2Paraparesis
12/2010 - 12/2009
2Paraplegia (Spastic Paraplegia)
12/2010 - 12/2009
2Aortic Rupture
10/2008 - 07/2007
1Cicatrix (Scar)
02/2024
1COVID-19
12/2023
1Supraventricular Tachycardia
05/2022
1Ischemic Stroke
01/2022
1Staphylococcal Infections
01/2022

Drug/Important Bio-Agent (IBA)

7Clopidogrel (Plavix)FDA Link
08/2021 - 08/2005
6MetalsIBA
12/2018 - 08/2006
6Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2007 - 08/2005
3CytokinesIBA
01/2022 - 03/2006
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 06/2010
3Prasugrel HydrochlorideFDA Link
01/2017 - 06/2015
2APTIBA
08/2022 - 08/2021
2omega-Chloroacetophenone (Mace)IBA
05/2022 - 06/2015
2N(4)-oleylcytosine arabinosideIBA
08/2021 - 09/2017
2Dichlorodiphenyldichloroethane (DDD)IBA
07/2020 - 07/2019
2Sirolimus (Rapamycin)FDA Link
01/2020 - 05/2007
2EnzymesIBA
12/2019 - 05/2005
2Anti-Arrhythmia AgentsIBA
01/2019 - 05/2018
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2019 - 09/2017
2Phenobarbital (Luminal)FDA Link
10/2006 - 08/2006
2Dihydrotachysterol (AT 10)IBA
11/2005 - 08/2005
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2005 - 08/2005
2Abciximab (ReoPro)FDA Link
11/2005 - 08/2005
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2005 - 08/2005
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2005 - 08/2005
1matrigelIBA
02/2024
1dalbavancinIBA
01/2022
1Phenprocoumon (Liquamar)FDA Link
08/2021
1AnticoagulantsIBA
08/2021
1apixabanIBA
08/2021
1Vitamin KFDA Link
08/2021

Therapy/Procedure

37Stents
10/2022 - 09/2003
33Therapeutics
02/2024 - 03/2002
9Transcatheter Aortic Valve Replacement
10/2022 - 10/2012
8Percutaneous Coronary Intervention
01/2023 - 08/2005
7Endovascular Aneurysm Repair
01/2015 - 12/2009
5Cell- and Tissue-Based Therapy (Cell Therapy)
02/2024 - 12/2006
5Catheter Ablation
05/2022 - 05/2018
5Prostheses and Implants (Prosthesis)
11/2017 - 09/2012
4Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
03/2024 - 11/2016
4Cardiac Resynchronization Therapy
03/2024 - 01/2015
4Transplantation
09/2011 - 12/2004
3Defibrillators (Defibrillator)
03/2024 - 07/2019
3Contraindications
02/2022 - 01/2020
3Drug Therapy (Chemotherapy)
10/2019 - 09/2017
3Endovascular Procedures
03/2015 - 10/2010
2Ligation
02/2024 - 01/2021
2Patient Readmission
01/2023 - 04/2013
2Drug-Eluting Stents
01/2022 - 10/2011
2Catheters
07/2020 - 02/2013
2Aftercare (After-Treatment)
01/2019 - 07/2009
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
06/2015 - 05/2005
2Sutures (Suture)
10/2007 - 08/2006
2Cell Transplantation
02/2006 - 05/2005
1Treatment Delay
12/2023
1Dual Anti-Platelet Therapy
08/2021
1ACT protocol
08/2021
1Anesthesia
01/2021